Comparative Assessment of the Treatment of Type 2 Diabetes Mellitus
| العنوان: | Comparative Assessment of the Treatment of Type 2 Diabetes Mellitus |
|---|---|
| المؤلفون: | Vesna Čapkun, Sanda Tesanović, Djurdja Dovzak-Kokić, Maja Radman, Slaven Kokić |
| المصدر: | Annals of Saudi Medicine. 22:163-166 |
| بيانات النشر: | King Faisal Specialist Hospital and Research Centre, 2002. |
| سنة النشر: | 2002 |
| مصطلحات موضوعية: | medicine.medical_specialty, Treatment regimen, business.industry, Insulin, medicine.medical_treatment, nutritional and metabolic diseases, Type 2 Diabetes Mellitus, NPH insulin, General Medicine, Gastroenterology, Metformin, Surgery, Glimepiride, Internal medicine, medicine, In patient, business, medicine.drug |
| الوصف: | Background: The objective of the study was to estimate the most successful way of treating patients with type 2 diabetes mellitus. Patients and Methods: A total of 87 patients with type 2 diabetes mellitus were selected for a three-month study. The patients were divided into three groups comprising 29 patients in each group, based upon the treatment regimen. Group 1 (BMI 32.3±3.6 kg/m 2 ) was treated with glimepiride and metformin; group 2 (BMI 27.9±3.9) was treated with daily doses of insulin mixture 30/70 and bed-time NPH insulin; and group 3 (BMI 30.2±4.8) was treated with a combination of three daily doses of lispo and metformin. The groups did not differ significantly in terms of sex and age. Results: Initially, there were significant statistical differences in HbA1c (P=0.035) between the three groups (9,21%±1.72%; 9.21%±1.54%; and 10,0%±1.73%, respectively). After three months, there were no statistically significant differences in HbA1c (P=0.66) between the groups (8.52%±1.7%; 8.03%±1.05%; and 8.0%±0.63%, respectively). Decreases in HbA1c were significant in all groups, but most pronounced in patients treated with lispro and metformin (17% on average). Conclusion: The study results suggest the need for establishing guidelines on how to treat type 2 diabetics. Ann Saudi Med 2002;22(3-4):163-166. |
| تدمد: | 0975-4466 0256-4947 |
| الوصول الحر: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26b374f7bcd740a2a4c56e4337c7819fTest https://doi.org/10.5144/0256-4947.2002.163Test |
| حقوق: | OPEN |
| رقم الانضمام: | edsair.doi.dedup.....26b374f7bcd740a2a4c56e4337c7819f |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 09754466 02564947 |
|---|